Sante Ventures
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States
Industries Focus
- Healthcare
- HealthTech
- Medtech
- Biotechnology
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2006
A life sciences venture capital firm investing in early-stage companies developing innovative medical technologies.
Founded in 2006, Sante Ventures has nearly $1 billion in capital under management. The firm focuses on early-stage investments in biotech, medtech, and healthtech sectors, aiming to build valuable, enduring companies.
Sante Ventures employs a disciplined portfolio strategy, combining deep healthcare domain expertise with an extensive network of industry contacts and resources. This approach has led to successful investments in companies like Farapulse, Claret Medical, and TVA Medical, contributing to improved patient health outcomes through advances in biology, medicine, and information technology.
Requirements
- Innovative medical technologies
- Early-stage companies
- Strong management teams
- Potential for significant impact on healthcare
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Farapulse
- Claret Medical
- TVA Medical
- Millipede Medical
- Molecular Templates
- AbVitro
- Explorys
Mentioned In
-
$24.95
-
$19.95
-
$49.95
-
$14.95
-
$39.95
-
$19.95
-
$24.95
-
$99.00
-
$299.00
Claim this Investor
Are you an official representative of Sante Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim